By Business/Source
Currency:USD
2020/FY
Stock NameRevenueRatio
Development and commercialization of precision therapies for genetically defined diseases7.87M100.00%
By Country/Region
Currency:USD
2020/FY
Stock NameRevenueRatio
United States7.87M100.00%